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Sprague-Dawley rats were given 0.02 ml of methylprednisolone (0.06 g/g body
wt) 6, 9, or 12 days postnatally. When compared with saline-treated controls, the
following effects on dendritic development in layers 3 and 5 of the parietal cortex
were observed: (1) no significant alteration in number of basal dendrites; (2)
initial increase (at 3 wk of age) in branchings near the perikaryon in the group
treated at 12 days; (3) decrease in number of branches at distances >270 ,um
from the perikaryon in layers 3 and 5 in all steroid-treated groups when sacrificed
at 6 wk; (4) decrease in number of intersections in layer 5 in all steroid-treated
groups when sacrificed at 6 wk; and (5) decrease in number of terminations in
layers 3 and 5 in all steroid-treated groups when sacrificed at 6 wk.
INTRODUCTION
Corticosteroids are used in the treatment of a variety of diseases of infancy and
childhood, as well as in pregnant women (1-4). Aside from their retarding effects
on growth, little is known about the long-term side effects on development of
chronic steroid administration in such patients (5, 6). This is particularly true with
respect to their effect on the developing nervous system.
There have been some reports of increased neurological deficits in infants and
children, as well as in the fetuses of pregnant women, after steroid treatment (7,
8). Clinical experience at Yale-New Haven Hospital has suggested, also, that neu-
rological sequelae may result from chronic steroid therapy in infancy (9).
In animals, experimental neonatal corticosteroid treatment has been shown to
cause an irreversible reduction in brain weight (10). Quantitative neurochemical
measurements have shown that steroids decrease the number of cells present as
well as the total amount of myclin lipids. Thus, Howard measured the amount
of DNA present in the brains of control and steroid-treated mice, as well as the
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RNA/DNA ratio and the cholesterol/DNA ratio in order to determine cell size,
cell number, and degree of myelination. Mice with subcutaneously implanted corti-
costerone (producing doses of 0.08-0.6 mg/day between 2 and 7 days of age)
showed, by 17 days of age, a decrease in total DNA, the RNA/DNA ratio, and
the cholesterol/DNA ratio in both the cerebrum and cerebellum (10). Follow-up
studies in adult mice (350 days) similarly treated during the neonatal period
showed a persisting decrease in total DNA and in the cholesterol/DNA ratio, but
no significant decrease in the RNA/DNA ratio (11). Subsequently, Cotterrell et
al. (12) studied reduction in cell number by labeling techniques, and confirmed
the demonstration by Howard of a decrease in cellularity; furthermore, this investi-
gation was able to attribute the reduction to a decrease in cell division as opposed
to an increase in cell destruction.
Behavioral experiments have shown that steroids can cause long-term functional
deficits in animals. After a single injection of 1 mg cortisol acetate on the day
of birth, for example, Sprague-Dawley rats exhibit decreased spontaneous explora-
tory locomotor activity (13). Similarly, Howard reported that mice treated as de-
scribed above with subcutaneously implanted corticosterone, initially exhibit an in-
creased voluntary running in activity wheels, but a decreased activity in exploration
in an open field. In addition, treated mice tend to show a poorer initial adjustment
to mazes. These data have been interprcted as consistent with emotional lability
(14).
Electrophysiological studies have shown that neonatal steroid administration in
the young rat can cause a retardation in the development of evoked cortical re-
sponses to visual, auditory, and sciatic nerve stimulation (15). Further, it has been
demonstrated that neonatal cortisol treatment delays the maturation of swimming
ability in rats, and that this delay corresponds to ontogenetic shifts in the character-
istics of the evoked potentials (16).
Although these neurochemical, behavioral, and electrophysiological studies sug-
gest, indirectly, that steroids may interfere with the normal myelination and den-
dritic development of nerve cells, they supply no direct evidence for steroid-induced
morphological changes in neurons. In humans and certain other species, it is known
that both myelination and dendritic formation continue well into the postnatal
period (17). Because certain conditions, such as hypothyroidism (18, 19), anoxia
(20), X-irradiation (21), and malnutrition (22-24) during this postnatal period
can cause permanent alterations in neuronal structure in animals, it is possible that
steroid administration might also affect the structure of developing neurons. In an
earlier report (25), we demonstrated that neonatal corticosteroid administration
in rats can cause significant alterations in the myelination of developing axons.
Specifically, we showed that neonatal treatment with steroids results in a decrease
in the frequency of myelinated fibers, a decrease in the mean number of lamellae
per axon, and a decrease in the number of lamellae for a given axon circumference.
We now report that, in addition, the proliferation of neuronal dendritic processes
is significantly altered after a single injection of steroid during the neonatal period.
MATERIALS AND METHODS
Sprague-Dawley rats were divided into four groups. One group (control) re-
ceived a single intramuscular dose of 0.02 ml saline (McGaw) 6 days postnatally.
The other three groups received 0.02 ml methylprednisolone (Depo-Medrol, Up-
john, 40 mg/ml) 6, 9, or 12 days postnatally. The rats were sacrificed at 3 or
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6 wk. Rats were decapitated by means of a guillotine. Brains were immediately
removed and weighed. Olfactory bulbs were not included. Frontal sections, about
2 mm in width were taken from the parietal cortex, and were placed into freshly
prepared Golgi-Cox fixative (K2Cr207, 10 mg in 450 ml distilled water, HgCl2,
10 mg in 450 ml distilled water, and KCrO,, 3 mg in 100 ml distilled water).
The tissues were incubated in the fixative solution for 6-8 wk at 37°C. They were
then dehydrated and embedded in celloidin, and cut into 90-/m sections. These
sections were next exposed to 1% aqueous NH4OH for about 20 sec and were
then dehydrated and mounted on glass slides.
Dendritic development was evaluated using pyramidal cells from layer 3 an
layer 5 of the parietal cortex (18). Fifteen to forty cells from each layer were
selected randomly according to the following criteria: (1) cells were chosen from
regions in which there was relatively little superimposition of cell bodies and
branchings from neighboring neurons, and (2) regions were selected in which
breakage of dendrites was minimal. Pyramidal cells thus selected for analysis were
drawn by tracing the projected outline of each cell and its dendrites on paper using
a Leitz microscope with drawing attachment.
The image of each neuronal perikaryon and its branches was projected onto
the center of a target, and all dendrites extending from the perikaryon were drawn
on a grid of 15 concentrically arranged circles, or zones, each of a radius which
represented a distance of 18 jum on the histological section. Using this method,
the following measurements were made (18, 26): (1) the number of dendrites
arising from the perikaryal surface (basal dendrites); (2) the number of dendrites
intersecting the zonal boundaries at successive distances of 18 M.m from the cell
body; (3) the number of branching points present in each zone; and (4) the num-
ber of dendritic endings in each zone.
Evaluation was done on a blind basis. Slides from experimental and control ani-
mals were coded prior to microscopic examination.
RESULTS
The changes in dendritic morphology resulting from corticosteroid treatment
were qualitatively similar in layers 3 and 5.
Steroid treatment did not alter the number of basal dendrites arising from the
perikaryon in either the 3- or 6-wk-old groups (Fig. 1).
Steroid treatment did have a significant effect on the distribution of branching
points surrounding each axon. Specifically, by 6 wk of age, steroids caused a de-
crease in the degree of branching at distances greater than 27 MAm from the neuronal
perikaryon. This is seen in Figs. 2 and 3. Interestingly, the peak incidence of
branching was not altered as a result of steroid treatment. Thus, in both control
and experimental groups, the peak of branching occurred at a distance of 36-72
,Mm from the center of the perikaryon). In fact, at early times after steroid treatment
(3-wk-old animals), the absolute number of dendrites branching close to the peri-
karyon was actually enhanced in rats treated at 12 days (Figs. 4 and 5). However,
by the age of 6 wk (Figs. 2 and 3), there was, as noted above, a significant decrease
in the number of dendrites branching farther (.270 Mum) from the perikaryon
in the treated animals when compared with their littermate controls. This decrease,
which was more pronounced in layer 5, is shown more clearly in Figs. 6 and 7.
These figures compare the number of intersections, branchings, and terminations
at distances >270 MAm from the perikaryon, and show that there was a significant
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FIG. 1. Mean number of basal dendrites (+ SD) in layer 3 (top)
of parietal cortex of 3-wk-old and 6-wk-old rats.
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FIG. 2. Distribution of branching points, layer 3, age 6 wk. (Each zone represents a distance
of 18 ,um on the histological section). 0 = control; A = 12 day; 0 = 9 day; g = 6 day.
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FIG. 3. Distribution of branching points, layer 5, age 6 wk. (Each zone represents a distance
of 18 um on the histological section). 0 = control; A = 12 day; 0 = 9 day; El = 6 day.
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decrease in the number of dendrites branching in the steroid-treated groups. Quali-
tatively, this difference can be seen by comparing Figs. 8 and 9 (3 wk), and Figs.
10 and 11 (6 wk).
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FIG. 4. Distribution of branching points, layer 3, age 3 wk. (Each zone represents a distance
of 18 jum on the histological section). * = control; A = 12 day; 0 = 9 day; j = 6 day.
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FIG. 5. Distribution of branching points, layer 5, age 3 wk. (Each zone represents a distance
of 18 ,xm on the histological section). 0 = control; A = 12 day; 0 = 9 day; L- = 6 day.
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FIG. 6. Mean number of intersections, branchings, and terminations at distances > 270 ,tm
from perikaryon, + SD, layer 3, age 6 wk.ODA AND HUTTENLOCHER
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FIG. 7. Mean number of intersections, branchings, and
from perikaryon, + SD, layer 5, age 6 wk.
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FIG. 8. Pyramidal cell in layer 5 of parietal cortex of corticosteroid-treated rat, age 3 wk.
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FIG. 9. Pyramidal cell in layer 5 of parietal cortex of control rat, age 3 wk.
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FIG. 10. Pyramidal cell in layer 5 of parietal cortex of corticosteroid-treated rat, age 6
wk.ODA AND HUTTENLOCHER
FIG. 11. Pyramidal cell in layer S of parietal cortex of control rat, age 6 wk.
In a pattern similar to that seen above, steroids caused a decrease in the number
of ending and intersecting points at distances >270 1um from the neuronal peri-
karyon. This effect is illustrated in Figs. 6 and 7.
DISCUSSION
We have described an experimental model which was used to evaluate the effects
of corticosteroid administration on structural changes in brain development. Earlier,
we reported significant effects of steroids on myelination. In the present study, we
report the observation of significant alterations in dendritic proliferation in neona-
tally treated rats.
Whether it is valid to extrapolate the results reported here for rats to the human
brain is an important question. The implications of the changes in myelination and
dendrite formation which we have reported should be viewed in terms of the
rationale behind some aspects of the experimental procedure.
First, the choice of rats as experimental animals is supported by comparative
studies of brain development. Such studies have indicated that increases in both
brain weight and cortical thickness follow a triphasic curve in both rats and humans
although the rate of growth in rats is much more rapid (27, 28).
Second, rats were not injected until 6 days postnatally rather than at birth be-
cause the cerebral cortex of rats at the time of birth is somewhat less developed
than the human cortex at birth. Specifically, the human brain at birth is similar
in development to that of a rat of approximately 5 days of age (29, 30).
Third, the dosage per gram of body weight of steroid chosen was comparable
to that used in humans on chronic steroid therapy.
Fourth, myelination and dendritic development were chosen for evaluation be-
cause it has been suggested that interference with these processes during the "vul-
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nerable period" which, in humans, includes the last trimester of gestation and the
first 18-24 postnatal months (31) may lead to serious motor, intellectual and be-
havioral studies (10-16) strongly suggest an interference with these processes.
In most mammals, structural, biochemical, and functional maturation of the
brain is incomplete at birth (32). The postnatal increase in cortical dimensions
is largely due to the increase in cell size, the growth of dendrites, and myelin deposi-
tion (33, 34).
Quantitative histological studies on the postnatal development in the rat have
demonstrated that prior to 6 days of age, very few dendrites appear, but by 12
days, the mean number of dendrites arising from the perikaryon has reached the
adult level. Subsequent development results in an increase in the extent of the den-
dritic field (26). Corresponding studies in the human (35) have demonstrated that
differentiation of dendritic ramifications has just commenced at birth. Between 3
and 6 mo, there is a striking growth in the dendritic plexus, and by the age of
2 yr,Ino further change in dendritic development can be demonstrated by present
methods.
It has been postulated that insults to developing organ systems during critical
stages of development may have irreversible long-term sequelae (30, 31, 36, 37).
In particular, the brain is likely to be most vulnerable to permanent alterations
during periods of maximum growth. It is thought that growth impairment induced
by injurious conditions does not alter the timing of the growth spurt in the brain
(17). Rather, brain injury is reflected by a decrease in the extent of the processes
which nevertheless occur at a set, preordained time. Therefore, some feel that the
brain is an organ with only one opportunity to accomplish its important develop-
mental events, and that once this opportunity is lost, it probably cannot be
recovered.
Earlier, we reported that the myelination process in steroid-treated rats is con-
siderably retarded (25). We now present evidence that the ability of dendrites
to proliferate, elongate, and branch at their terminal arborizations is also signifiantly
decreased by such treatment. This impairment is reflected by a decrease in the
number of dendrites and their branches at distances farther from the perikaryon.
This effect was noticeable in both layer 3 and layer 5 of the parietal cortex. An
exception to this trend was shown by rats treated at 12 days and sacrificed at 3
wk of age, which demonstrated significantly increased dendritic development in
layers 3 and 5. By the age of 6 wk, this advantage had been lost. In this regard,
it is interesting to note that, although the mechanism of action is different (38,
39), a similar effect has been observed in synaptogenesis in hyperthyroid rats. Such
animals have been found to exhibit an initial acceleration of cerebellar synapse
formation but an ultimate reduction in the total number of synapses (40). Similarly,
lung development in steroid-treated animals is initially accelerated, but ultimately
reduced (41, 42). It appears that the consequences of an insult are complex, and
may depend not only upon the age and type of cell it affects, but also on the time
of the interference.
These structural changes in the pattern of dendritic development due to treatment
with steroids during the neonatal period may possibly explain the results of some
of the behavioral studies. The "brain damage behavior" syndrome in humans has
been characterized by decreased motor coordination and emotional lability (43).
More recently, young children with profound mental deficiency have been observed
to have abnormalities of cortical dendritic development as the only or the major
pathologic finding (44). The structural data reported here are consistent with
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known neurochemical and functional changes, and suggest that brain damage syn-
dromes might be caused by interference with the processes of neuron maturation
which have their maximal rate during the brain growth spurt.
The results of the present study leave the mechanism of action of steroids on
the central nervous system open to speculation. The derangements in gross brain
size, myelination, and dendritic proliferation may be a direct effect of the steroids
on the brain. On the other hand, the defects in CNS development documented
here could be due to a secondary effect of the steroids on other organ systems,
such as functional malnutrition due to defective intestinal absorption. Still a third
possibility is that the steroids exert their effect via the functional thymectomy they
are known to produce and that the central nervous system changes are part of
the spectrum of defects known as the "runting syndrome" (45).
Regardless of its mechanism of action, neonatal corticosteroid treatment has been
demonstrated to have an adverse effect in the rat on the development of the struc-
tural components of the central nervous system, particularly with regard to myelina-
tion and dendritic development. These changes in morphology provide an explana-
tion for formerly observed neurochemical, functional, and behavioral alterations
in the central nervous system.
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